Reactivation of low avidity tumor-specific CD8(+) T cells associates with immunotherapeutic efficacy of anti-PD-1

BACKGROUND: CD8(+) T cells are a highly diverse population of cells with distinct phenotypic functions that can influence immunotherapy outcomes. Further insights on the roles of CD8(+) specificities and TCR avidity of naturally arising tumor-specific T cells, where both high and low avidity T cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugiyarto, Gessa, Lau, Doreen, Hill, Samuel Luke, Arcia-Anaya, David, Boulanger, Denise S M, Parkes, Eileen E, James, Edward, Elliott, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432680/
https://www.ncbi.nlm.nih.gov/pubmed/37586767
http://dx.doi.org/10.1136/jitc-2023-007114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432680/
https://www.ncbi.nlm.nih.gov/pubmed/37586767
http://dx.doi.org/10.1136/jitc-2023-007114

Ejemplares similares